Our strategy
We focus on finding new medicines and diagnostics and establishing data-based insights that evolve the practice of medicine and help patients live longer, better lives.
Healthcare is undergoing tremendous changes but our vision is clear. We are doing now what patients need next. From developing diagnostics and treatments, to harnessing the power of data to shape innovations of the future, we are an integrated healthcare company with a culture of integrity, courage and passion.
For over 125 years, we’ve been developing diagnostics and medicines for a wide range of chronic and life threatening health conditions that continue to revolutionise healthcare. Being a family-owned company allows us to focus on long-lasting investments, take greater risks and explore innovative new ways to improve people’s health around the world.
As a global leader in healthcare, we are one of the world’s largest biotech companies and the leading supplier of in-vitro diagnostics. We’re an innovator across major disease areas, including oncology, neurology, infectious diseases, and ophthalmology. We’ve partnered with many forward-thinking, entrepreneurial and groundbreaking organisations that have one thing in common - the belief that cutting-edge science and technology can and will improve human health.
Our strategy
Fitting the right treatment
We focus on fitting treatments to patients: providing the right therapy for the right patient to ensure the best response at the right time for the right value. Our approach combines our rich expertise in pharmaceuticals and diagnostics with expanded data science capabilities to drive more effective and efficient research and enable better therapeutic decisions for patients.
Further reading:
Partnerships drive us forward
Working in partnership with third parties, we are better positioned to offer integrated solutions that improve medical and health outcomes. We work with stakeholders across the healthcare ecosystem to broaden access to our solutions for people who need them.
Additionally, we are passionate about advancing science, regardless of where it comes from, by identifying the best innovations, whether internal or external, and delivering them to patients.
Further reading:
Excellence in science
Our pursuit of excellence in science rests on four key elements: an exceptionally broad and deep understanding of disease biology; the seamless integration of our capabilities in pharmaceuticals and diagnostics; a diversity of approaches to maximise innovation; and a long-term vision
Further reading:
Our people make the difference
Delivering on our commitments takes people with integrity, courage, and passion. Our people are driven to advance science and create a better tomorrow for patients.
Our leadership embraces diversity and inclusion. Different backgrounds, perspectives and experiences foster innovative solutions for the benefit of patients. Our ways of working enable agile and networked responses to the ever increasing pace of change by balancing the need for stability, speed and flexibility.
Further reading:
Diversity in innovation
Our set-up is designed for innovation. Our autonomous research and development centres and alliances with over 250 external partners foster a diversity of scientific approaches, creativity and agility. Our global geographical scale and reach enables us to attract talent in the leading global science clusters and to quickly bring our solutions to people who need them.
Further reading:
Value for all
We are committed to delivering value for all our stakeholders and being a partner of choice. We do this by continually bringing significant medical benefits for patients, healthcare providers and payers, offering a great place to work for employees, delivering a sustainable and positive contribution to society and earning competitive returns for our investors.
Further reading: